A study of phage therapy for severe infections
Part of Infections clinical trials.
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a severe infection that was treated with phage therapy (a type of virus treatment that kills bacteria) at the Hospices Civils de Lyon hospital between 2015 and 2033.
- You were given a study information sheet about the PHAGEinLYON Clinic research project.
- You do not object to being part of this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.
This trial is an organized clinic to help patients request bacteriophage (phage) therapy. It mainly checks that you were referred to the Lyon hospital for a phage therapy request and that you agree to be part of the program.
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
Hear when a new Severe Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.